Congressional Trader
Live

AZN congressional trades

13 matched disclosures

Track congressional trades for AZN
Tracked disclosures
13
Lawmakers
5
Buy / sell
9 / 4
Avg post-trade move
N/A
Latest filing 2026-01-13

AZN congressional trades snapshot

This page summarizes public STOCK Act disclosures involving AZN. It is useful for seeing which lawmakers reported AZN transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Jan 13, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the AZN congressional trade page shows

Congressional Trader tracks 13 public STOCK Act disclosures for AZNacross 5 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent AZN filing shown here was filed on Jan 13, 2026 by Julia Letlow as a purchase. Related lawmakers include Lisa C. McClain, Gilbert Ray Cisneros, Bruce Westerman, Val T. Hoyle, Julia Letlow.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
Julia LetlowR-LAHouse
No committee data
Filed Jan 13, 2026
Delay 36 days
View filing
AZNNotable
AstraZeneca PLC - American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jan 12, 2026
Delay 25 days
View filing
AZNNotable
AstraZeneca PLC - American
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Dec 15, 2025
Delay 26 days
View filing
AZNNotable
AstraZeneca PLC - American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Nov 21, 2025
Delay 21 days
View filing
AstraZeneca PLC - American
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Nov 21, 2025
Delay 22 days
View filing
AstraZeneca PLC - American
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Nov 21, 2025
Delay 22 days
View filing
AZNNotable
AstraZeneca PLC - American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Nov 18, 2025
Delay 28 days
View filing
AstraZeneca PLC - American
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Val T. HoyleD-ORHouse
No committee data
Filed Oct 10, 2025
Delay 17 days
View filing
AZNNotable
AstraZeneca PLC - American
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Val T. HoyleD-ORHouse
No committee data
Filed Sep 12, 2025
Delay 318 days
View filing
AZNNotable
AstraZeneca PLC - American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Aug 13, 2025
Delay 22 days
View filing
AstraZeneca PLC - American
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Aug 13, 2025
Delay 65 days
View filing
AZNNotable
AstraZeneca PLC - American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 12, 2025
Delay 21 days
View filing
AstraZeneca PLC - American Depositary Shares
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Apr 16, 2025
Delay 44 days
View filing
AZNNotable
AstraZeneca PLC - American Depositary Shares
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded AZN?

Recent AZN disclosures include Lisa C. McClain, Gilbert Ray Cisneros, Bruce Westerman, Val T. Hoyle, Julia Letlow.

What is the buy/sell mix for AZN?

The visible sample currently shows 9 purchases and 4 sales or partial sales.

Should I trade based on AZN disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.